Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin. Depending on duration and level of exposure, it can result in cancers including leukemia, and blood cancer of the bone marrow and blood disorders which can be life-threatening. Benzene is found in the environment from natural sources and human activity. Humans around the world are exposed to it from multiple sources and pathways, including inhalation, through the skin, and orally. To date, Bayer has no known reports of adverse events related to this recall.
The affected Lotrimin® and Tinactin® spray products are over the counter antifungal products, sold individually or in combo packs. The impacted products are:
Lotrimin® Anti-Fungal (AF) Athlete's Foot Powder Spray
Lotrimin® Anti-Fungal Jock Itch (AFJI) Athlete's Foot Powder Spray
Lotrimin® Anti-Fungal (AF) Athlete’s Foot Deodorant Powder Spray
Lotrimin® AF Athlete's Foot Liquid Spray
Lotrimin® AF Athlete’s Foot Daily Prevention Deodorant Powder Spray
Tinactin® Jock Itch (JI) Powder Spray
Tinactin® Athlete’s Foot Deodorant Powder Spray
Tinactin® Athlete’s Foot Powder Spray
Tinactin® Athlete’s Foot Liquid Spray
Product images and information on which lot numbers fall under this recall are available at: https://livewell.bayer.com/document/2011External Link Disclaimer.External Link Disclaimer
There are no issues of concern with Lotrimin®/Tinactin® creams, including Lotrimin® Ultra, or any other Bayer products.
The recalled products are all packaged in aerosol spray cans. The products were distributed in the U.S., Puerto Rico, Canada and Mexico through a variety of retail channels.